NCT01411332View on ClinicalTrials.gov

Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 11, 2017

Study Completion Date

November 22, 2021

Conditions
Prostate CancerProstate Adenocarcinoma
Interventions
RADIATION

SIMRT

A total dose of 80 Gy will be delivered in 40 fractions to the Clinical Target Volume (CTV).

RADIATION

HTIMRT

Dose escalation to the Multiparametric MRI (MP-MRI) by dose painting at 2.35-2.40 Gy per fraction, while the rest of the Clinical Target Volume (CTV) receives 2.0 Gy a fraction to 76 Gy. The hypofractionated targeted (HT) boost region will receive an absolute dose of 89.3-91.2 Gy. Assuming an α/β ratio of 3.0, this would be equivalent to 95.5 Gy in 2.0 Gy fractions.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT01411332 - Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial | Biotech Hunter | Biotech Hunter